Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 94 M109 M95 M95 M103 M114 M 407 M Research & development —————— — Operating income 536 M778 M777 M602 M678 M858 M 2.92 B Non-Operating Income, Total 19 M2 M-14 M-8 M2 M5 M -15 M Interest expense, net of interest capitalized 145 M151 M159 M165 M162 M183 M 669 M Non-Operating Income, excl. Interest Expenses -143 M-152 M-168 M-168 M-167 M-190 M -693 M Unusual income/expense 17 M3 M-5 M-5 M7 M12 M 9 M Pretax income 410 M629 M604 M429 M518 M680 M 2.23 B Equity in earnings —————— — Taxes 110 M187 M183 M131 M135 M198 M 647 M Non-controlling/minority interest 02 M1 M1 M-2 M0 0 After tax other income/expense —————— — Net income before discontinued operations 300 M440 M420 M297 M385 M482 M 1.58 B Discontinued operations —————— — Net income 300 M440 M420 M297 M385 M482 M 1.58 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 300 M440 M420 M297 M385 M482 M 1.58 B Basic earnings per share (Basic EPS) 1.251.851.791.291.682.12 6.88 Diluted earnings per share (Diluted EPS) 1.231.841.781.271.662.1 6.81 Average basic shares outstanding 240 M237 M234 M236 M229 M227 M — Diluted shares outstanding 243 M239 M237 M238 M232 M229 M — EBITDA 577 M821 M823 M649 M728 M907 M 3.11 B EBIT 536 M778 M777 M602 M678 M858 M 2.92 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 41 M43 M46 M47 M50 M49 M 192 M